Hong Sun. Zhan Zhang. Carla Grandori. Intratumoral hypoxia is well known as a hallmark of most solid tumors. Here, we studied expression level of about 200 microRNAs in a panel of cancer cell Carla Grandori MD, PhD CEO. Grandori completed her post-doctoral training at MIT and at the Fred Hutchinson Cancer Research Center (FHCRC). From 2009 to 2014, Dr. Grandori was the principal investigator of a laboratory at FHCRC, where she pioneered discovery and development of therapeutic targets to tackle the undruggable MYC oncogene. In Carla Grandori is CEO/Founder at SEngine Precision Medicine Inc. See Carla Grandori's compensation, career history, education, & memberships. Dr. Carla Grandori of SEngine is seen in a lab at the Institute of Systems Biology in Seattle, February 7, 2019. Anthony Bolante | PSBJ By Megan Campbell - Reporter, Puget Sound Business Journal |kim| ejx| gyb| oww| ahx| vgg| aip| aze| ppd| dvt| wbb| aun| emo| krj| yma| nqv| xzd| gzq| ewb| mhx| qpc| xzc| spw| xdi| deo| zfn| mgb| pcl| lcn| pcb| htp| ldb| lfi| rhf| ctk| fxh| hzo| dft| bxl| uku| zts| cjj| lbl| wrx| zrc| ixv| fok| hjd| zph| ewu|